Key Developments For United American Healthcare Corp
United American Healthcare Corp (UAHC.O) (Consolidated Issue listed on NASDAQ Capital Market)
United American Healthcare Corp. Announces Appointment of CFO
United American Healthcare Corp. announced that Anita R. Davis has been named Chief Financial Officer (CFO) effective August 28, 2009. Davis replaces Stephen D. Harris, who has resigned as Executive Vice President and Chief Financial Officer.
United American Healthcare Corp. Corporation Announces Stock Repurchase Program
United American Healthcare Corp. announced that its Board of Directors has approved a share repurchase program, authorizing the Company to repurchase up to $1.0 million of its outstanding common stock.
United American Healthcare Corp. Announces Resignation and Appointment Of President, CEO and CFO-Form 8-K
United American Healthcare Corp. announced in its form 8-K that Mr. Lawry Trevor-Deutsch resigned as President, Chief Executive Officer, Chief Financial Officer, Director, and Chairman. On May 12, 2008, Mr. Benoit Laliberté was appointed by the board of directors and consented to act as our President, Chief Executive Officer, Chief Financial Officer, Chairman, and Director. Mr. Laliberté will serve in an interim capacity until a permanent replacement for Mr. Trevor-Deutsch can be located.
United American Healthcare Corp. To Discontinue Quarterly Guidance
United American Healthcare Corp. announced that it has chosen to discontinue quarterly financial guidance.
United American Healthcare Corp. Completes $6.50 million Private Placement
United American Healthcare Corporation announced that it has raised gross proceeds of $6.50 million through the sale of 1,000,000 newly issued shares of its common stock to certain institutional and other accredited investors at a price of $6.50 per share. The investors also received warrants to purchase 100,000 shares of the Company's common stock at an exercise price of $8.50 per share and expiring in December 2011. Security Research Associates, Inc. and Moors & Cabot acted as co-placement agents for the offering. The net proceeds from the private placement will be used principally for start-up costs associated with the Company's Tennessee subsidiary's new Medicare Advantage contract with the Centers for Medicare & Medicaid. The remainder is to be used for working capital and general corporate purposes.
